AXT vs Advantest: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

AXT Inc (AXTI)

Q3 202622 Jun – 9 Sep 2026

▲3▼1

AXT Soars on AI InP Demand, Record Prices, Big Capital Raise

AI-driven indium phosphide demand Q2 revenue jumped 160% to $47.6M, gross margin hit 44.9%, and backlog exceeded $100M as AI data centers drove demand for indium phosphide used in high-speed optical connections.
This is the core fundamental driver of the stock's surge this period.
Record price hikes and supply deals Record InP price increases above 10% lifted shares, while supply deals with Casela, Coherent, and Lumentum—including prepayments through 2031—locked in revenue and reduced export and payment risks.
Pricing power and long-term contracts directly boosted investor confidence and revenue visibility.
Massive capital raise for capacity expansion AXT raised $632M, ending with $748.8M cash to double InP capacity in 2026 and expand again in 2027, positioning for co-packaged optics from late 2027.
The capital raise funds growth and signals confidence in future demand.
Competition and uncertain future revenue Rising competition from Coherent and Lumentum remains a risk, and future co-packaged optics revenue is still uncertain and years away.
This is the main counterweight to the positive drivers.

August 202631 Jul – 9 Sep 2026

▲4

AXT's AI-Driven InP Boom: Record Results, Price Hikes, Supply Deals

Blowout Q2 Earnings AXT reported Q2 revenue up 160% to $47.6 million and gross margin expanding to 44.9% from 8%, driven by record indium phosphide sales for AI data centers. This profit surge directly boosts investor confidence and the stock price.
It's the core fundamental catalyst that kicked off the period's rally.
Record InP Price Hikes A report of Q4 indium phosphide substrate price increases exceeding 10%—the largest on record—sent AXT shares up 13.7% in a day. Higher prices mean more revenue and profit per wafer, directly lifting AXT's earnings potential.
It's a new pricing catalyst that directly boosts AXT's core product economics.
Expanded Supply Agreements AXT signed long-term InP supply deals with Casela, Coherent, and Lumentum, including prepayments and commitments through 2031. With demand already exceeding capacity, these contracts lock in future revenue and improve visibility, supporting the stock.
It shows concrete customer commitments that de-risk future growth.
Strong Liquidity for Expansion AXT ended Q2 with $748.8 million in cash after a $632 million offering, funding a doubling of InP capacity in 2026 and another expansion in 2027. This financial strength lets AXT meet soaring AI demand, but rising competition from Coherent and Lumentum is a risk.
It explains how AXT can scale to capture demand, while noting a real counterweight.

Latest31 Jul – 9 Sep 2026

▲4

AXT's AI-Driven InP Boom: Record Results, Price Hikes, Supply Deals

Blowout Q2 Earnings AXT reported Q2 revenue up 160% to $47.6 million and gross margin expanding to 44.9% from 8%, driven by record indium phosphide sales for AI data centers. This profit surge directly boosts investor confidence and the stock price.
It's the core fundamental catalyst that kicked off the period's rally.
Record InP Price Hikes A report of Q4 indium phosphide substrate price increases exceeding 10%—the largest on record—sent AXT shares up 13.7% in a day. Higher prices mean more revenue and profit per wafer, directly lifting AXT's earnings potential.
It's a new pricing catalyst that directly boosts AXT's core product economics.
Expanded Supply Agreements AXT signed long-term InP supply deals with Casela, Coherent, and Lumentum, including prepayments and commitments through 2031. With demand already exceeding capacity, these contracts lock in future revenue and improve visibility, supporting the stock.
It shows concrete customer commitments that de-risk future growth.
Strong Liquidity for Expansion AXT ended Q2 with $748.8 million in cash after a $632 million offering, funding a doubling of InP capacity in 2026 and another expansion in 2027. This financial strength lets AXT meet soaring AI demand, but rising competition from Coherent and Lumentum is a risk.
It explains how AXT can scale to capture demand, while noting a real counterweight.

July 202622 Jun – 22 Jul 2026

▲4

AXT's AI-Driven Indium Phosphide Demand Surges with New Supply Deals

Record Indium Phosphide Revenue and Backlog AXT expects record second-quarter Indium Phosphide revenue, driven by AI data center demand. The company has already secured about $34 million in Q2 revenue and has a backlog exceeding $100 million, the highest ever. This strong demand pushes the stock up as investors see accelerating growth.
This point directly explains the surge in demand for AXT's core product, a key driver of the stock's recent rise.
New Supply Agreements Reduce Risk and Lock in Revenue AXT signed a $25.4 million supply deal with China's Casela for 2027 and a three-year agreement with Coherent, including a $22.3 million prepayment. These deals limit export and payment risks and provide revenue visibility, boosting investor confidence and the stock price.
These agreements are new, material contracts that de-risk future revenue and support the bullish case for AXTI.
Expansion into Co-Packaged Optics for Future Growth AXT is positioning for co-packaged optics, a next-generation AI data center technology, with commercial opportunities expected from late 2027. This potential new revenue stream, alongside capacity expansion, gives investors a longer-term growth narrative that supports the stock.
This highlights a new growth avenue that could drive future demand, relevant to the big picture of why AXTI is moving.
Analyst Upgrade and Board Appointment Northland reiterated an Outperform rating and raised its price target to $125, citing a positive conference appearance. AXT also appointed a new board member with strong financial experience. These developments reinforce positive sentiment and support the stock's upward momentum.
Analyst actions and governance improvements can influence investor perception and are part of the current positive narrative.

22 Jun – 22 Jul 2026

▲4

AXT's AI-Driven Indium Phosphide Demand Surges with New Supply Deals

Record Indium Phosphide Revenue and Backlog AXT expects record second-quarter Indium Phosphide revenue, driven by AI data center demand. The company has already secured about $34 million in Q2 revenue and has a backlog exceeding $100 million, the highest ever. This strong demand pushes the stock up as investors see accelerating growth.
This point directly explains the surge in demand for AXT's core product, a key driver of the stock's recent rise.
New Supply Agreements Reduce Risk and Lock in Revenue AXT signed a $25.4 million supply deal with China's Casela for 2027 and a three-year agreement with Coherent, including a $22.3 million prepayment. These deals limit export and payment risks and provide revenue visibility, boosting investor confidence and the stock price.
These agreements are new, material contracts that de-risk future revenue and support the bullish case for AXTI.
Expansion into Co-Packaged Optics for Future Growth AXT is positioning for co-packaged optics, a next-generation AI data center technology, with commercial opportunities expected from late 2027. This potential new revenue stream, alongside capacity expansion, gives investors a longer-term growth narrative that supports the stock.
This highlights a new growth avenue that could drive future demand, relevant to the big picture of why AXTI is moving.
Analyst Upgrade and Board Appointment Northland reiterated an Outperform rating and raised its price target to $125, citing a positive conference appearance. AXT also appointed a new board member with strong financial experience. These developments reinforce positive sentiment and support the stock's upward momentum.
Analyst actions and governance improvements can influence investor perception and are part of the current positive narrative.

Advantest Corp. (6857.JP)

Q3 202623 Jun – 7 Aug 2026

▲2▼2

Advantest gains on AI test demand, guidance raise; China and payback fears weigh

AI test demand and raised guidance Advantest benefits from strong demand for AI chip testing and raised its full-year net profit guidance to ¥660bn. The stock surged on robust earnings and SEMI's forecast of 23.2% equipment sales growth in 2026.
This is the main positive force behind the stock's performance in July.
Silicon photonics partnership and duopoly pricing power Advantest formed a silicon photonics partnership with OpenLight and holds duopoly pricing power with Teradyne, controlling 85–90% of the market. This strengthens its competitive position and pricing ability.
It highlights a new partnership and structural advantage supporting the stock.
AI-spending payback fears and China competition Fears that AI spending may not pay off triggered sharp selloffs, with the stock down 6–10% in July. China's chipmaking advances (Yuliangsheng, CXMT) threaten oversupply and competition, while Moonshot's open-weight AI model renewed concerns about faster Chinese progress.
These are the key risks that caused volatility and downward pressure.
Macro and cost pass-through worries Apple/Microsoft AI cost pass-through worries, Middle East tensions, and oil prices add further volatility. The stock remains highly sensitive to sentiment swings despite solid fundamentals.
These external factors contributed to price swings and investor uncertainty.

July 202623 Jun – 7 Aug 2026

▲2▼2

Advantest gains on AI test demand, guidance raise; China and payback fears weigh

AI test demand and raised guidance Advantest benefits from strong demand for AI chip testing and raised its full-year net profit guidance to ¥660bn. The stock surged on robust earnings and SEMI's forecast of 23.2% equipment sales growth in 2026.
This is the main positive force behind the stock's performance in July.
Silicon photonics partnership and duopoly pricing power Advantest formed a silicon photonics partnership with OpenLight and holds duopoly pricing power with Teradyne, controlling 85–90% of the market. This strengthens its competitive position and pricing ability.
It highlights a new partnership and structural advantage supporting the stock.
AI-spending payback fears and China competition Fears that AI spending may not pay off triggered sharp selloffs, with the stock down 6–10% in July. China's chipmaking advances (Yuliangsheng, CXMT) threaten oversupply and competition, while Moonshot's open-weight AI model renewed concerns about faster Chinese progress.
These are the key risks that caused volatility and downward pressure.
Macro and cost pass-through worries Apple/Microsoft AI cost pass-through worries, Middle East tensions, and oil prices add further volatility. The stock remains highly sensitive to sentiment swings despite solid fundamentals.
These external factors contributed to price swings and investor uncertainty.

Latest15 Jul – 7 Aug 2026

▲3▼1

Advantest rides AI test boom, strong earnings, and record equipment demand

Strong earnings revive AI chip sentiment Advantest reported stronger-than-expected earnings, triggering renewed buying in AI-related stocks and lifting the Nikkei. The results eased fears that AI spending was slowing, showing test demand for AI chips remains robust and supporting the stock's price.
This is the period's biggest company-specific catalyst, directly driving Advantest shares and the market.
Alphabet capex lifts pick-and-shovel demand Alphabet raised its capital investment plan, boosting demand for semiconductor equipment and testing. Advantest gained as a pick-and-shovel stock, since more AI data-center spending means more chips and more testing equipment needed, supporting future revenue.
It explains a key demand driver behind Advantest's gains this period.
Equipment sales forecast to grow five years SEMI forecasts global chip equipment sales rising 23.2% in 2026 to $165.9 billion, with the semiconductor market breaking $1 trillion. Analysts cite Advantest's better-than-expected results as evidence the AI-driven upcycle continues, supporting the stock.
It gives the big-picture industry backdrop confirming Advantest's growth runway.
AI selloff and China model fears hit chips A broad AI and chip selloff hit Advantest, which fell about 7% in Japan as Kioxia and Tokyo Electron plunged. China's Moonshot unveiled a powerful open-weight AI model, reinforcing fears Chinese developers are advancing faster than expected, pressuring chip stocks.
It is the main counterweight this period, showing real risk to Advantest's rally.

24 Jul – 31 Jul 2026

▲2▼2

Advantest swings on AI-spending fears, then a record profit upgrade

AI spending fears hit chip stocks Alphabet's bigger AI investment and negative cash flow sparked a global tech selloff; Advantest fell 6.33% on July 24 and about 10% on July 28 as investors questioned whether AI spending pays off.
Explains the sharp selloff that dominated the start of the period.
China chipmaking advance stokes competition Reports that China's Shanghai Yuliangsheng began mass-producing chipmaking technology long dominated by ASML, plus CXMT's debut, raised fears of Chinese capacity expansion and oversupply, dragging Advantest down with the sector.
A new competitive threat that added to the selloff pressure.
Profit forecast raised on AI test demand Advantest lifted its full-year net profit forecast to 660 billion yen from 465.5 billion, and operating profit to 846 billion yen, saying testing demand for AI inference chips is far stronger than assumed.
The core company-specific news that reversed sentiment and answers why the stock moved.
AI earnings spark record rebound Strong Microsoft and Amazon AI earnings restored confidence; Advantest surged nearly 18% on July 31 as Asian chip stocks staged a record rally, though the Kospi still ended July down 22%.
Shows the powerful recovery and the still-fragile market backdrop.

23 Jun – 9 Jul 2026

▲3

Advantest rides AI test demand, silicon photonics push, and sector swings

Silicon photonics test partnership Advantest teamed with OpenLight to build test solutions for silicon photonics, a key optical technology for AI data centers. This opens a new market for Advantest's test equipment as optical interconnects scale, supporting future revenue growth.
New partnership directly expands Advantest's addressable market in AI infrastructure.
Duopoly pricing power Advantest and Teradyne together control 85-90% of the chip test equipment market. This near-monopoly lets them keep prices high and earn strong returns, as rising chip complexity increases the amount of testing needed per chip.
Highlights structural competitive advantage that supports long-term profitability.
AI chip cost pass-through worries Apple and Microsoft raised prices on devices because AI chip costs are climbing, and their shares fell. This sparked a tech selloff that dragged Advantest down over 6% in a day, as investors feared slower demand for chips and test equipment.
Shows a real counterweight: rising costs could dampen end-demand for AI chips.
Sector rebound on AI optimism Advantest and other chip stocks rebounded as US semiconductor shares rose and investors stayed confident in long-term AI spending. Reports that China may allow limited Nvidia H200 purchases and Meta's new data center also lifted sentiment, though Middle East tensions and oil prices remain a risk.
Captures the latest positive momentum from AI investment logic and sector rotation.